{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:47:31Z","timestamp":1777855651026,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To develop effective HIV prevention strategies to guide public health policy the main sources of infection in HIV prevention studies must be identified. Accordingly, we devised a statistical approach that estimates the relative contribution of different sources of infection in community-randomized trials of infectious disease prevention using deep- (or next generation) sequenced pathogen data. We applied this approach to the Botswana Combination Prevention Project (BCPP) and estimated that 90% [95% Confidence Interval (CI): 80\u201394] of new infections in communities that received combination prevention (including universal HIV test-and-treat) originated from individuals residing in communities outside the trial area. We estimate from our model that the relative benefit of providing the BCPP intervention to all communities nationwide would be a 59% [3\u201387] reduction in transmissions to recipients in trial communities, exceeding the 30% reduction observed when providing the BCPP intervention to trial communities only. Our results suggest that the impact of the BCPP trial intervention was curtailed by sources of transmission outside the trial area and could be considerably larger if applied nationally. We recommend that the impact of sources of transmission beyond the reach of the intervention be considered when designing and evaluating interventions to inform public health programs.<\/jats:p>","DOI":"10.1038\/s41467-026-70203-x","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:34:01Z","timestamp":1773470041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unpacking sources of transmission in HIV prevention trials with deep-sequence pathogen data"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3388-9892","authenticated-orcid":false,"given":"Lerato E.","family":"Magosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Tchetgen","family":"Tchetgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad","family":"Novitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Pretorius Holme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam","family":"Bachanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refeletswe","family":"Lebelonyane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-4592","authenticated-orcid":false,"given":"Sikhulile","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen E.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tendani","family":"Gaolathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Lockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Essex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2772-6242","authenticated-orcid":false,"given":"Victor","family":"De Gruttola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-9213","authenticated-orcid":false,"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"70203_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1812281","volume":"381","author":"J Makhema","year":"2019","unstructured":"Makhema, J. et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N. Engl. J. Med. 381, 230\u2013242 (2019).","journal-title":"N. Engl. J. Med."},{"key":"70203_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1814556","volume":"381","author":"RJ Hayes","year":"2019","unstructured":"Hayes, R. J. et al. Effect of universal testing and treatment on HIV incidence\u2014HPTN 071 (PopART). N. Engl. J. Med. 381, 207\u2013218 (2019).","journal-title":"N. Engl. J. Med."},{"key":"70203_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1056\/NEJMoa1809866","volume":"381","author":"DV Havlir","year":"2019","unstructured":"Havlir, D. V. et al. HIV testing and treatment with the use of a community health approach in rural Africa. N. Engl. J. Med. 381, 219\u2013229 (2019).","journal-title":"N. Engl. J. Med."},{"key":"70203_CR4","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S2352-3018(17)30205-9","volume":"5","author":"CC Iwuji","year":"2018","unstructured":"Iwuji, C. C. et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 5, e116\u2013e125 (2018).","journal-title":"Lancet HIV"},{"key":"70203_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1056\/NEJMe1907279","volume":"381","author":"SS Abdool Karim","year":"2019","unstructured":"Abdool Karim, S. S. HIV-1 epidemic control\u2014insights from test-and-treat trials. N. Engl. J. Med. 381, 286\u2013288 (2019).","journal-title":"N. Engl. J. Med."},{"key":"70203_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/em-2015-0016","volume":"5","author":"NB Carnegie","year":"2016","unstructured":"Carnegie, N. B., Wang, R. & Gruttola, V. D. Estimation of the overall treatment effect in the presence of interference in cluster-randomized trials of infectious disease prevention. Epidemiol. Methods 5, 57\u201368 (2016).","journal-title":"Epidemiol. Methods"},{"key":"70203_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a115884","volume":"133","author":"ME Halloran","year":"1991","unstructured":"Halloran, M. E. et al. Direct and indirect effects in vaccine efficacy and effectiveness. Am. J. Epidemiol. 133, 323\u201331 (1991).","journal-title":"Am. J. Epidemiol."},{"key":"70203_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1740774514523351","volume":"11","author":"R Wang","year":"2014","unstructured":"Wang, R. et al. Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Clin. Trials 11, 309\u2013318 (2014).","journal-title":"Clin. Trials"},{"key":"70203_CR9","doi-asserted-by":"crossref","unstructured":"Magosi, L. E. et al. Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial\u2013BCPP\/Ya Tsie trial. eLife 11, e72657 (2022).","DOI":"10.7554\/eLife.72657"},{"key":"70203_CR10","first-page":"209","volume":"63","author":"SK Chan","year":"2014","unstructured":"Chan, S. K. et al. Likely female-to-female sexual transmission of HIV-Texas, 2012. Morb. Mortal. Wkly. Rep. 63, 209\u2013212 (2014).","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"70203_CR11","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S2352-3018(20)30103-X","volume":"7","author":"KE Wirth","year":"2020","unstructured":"Wirth, K. E. et al. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie\/BCPP): a cluster-randomised trial. Lancet HIV 7, e422\u2013e433 (2020).","journal-title":"Lancet HIV"},{"key":"70203_CR12","unstructured":"U.S. Census Bureau Population Division, I.D.B., September 2018 release, available at https:\/\/www.census.gov\/data-tools\/demo\/idb\/informationGateway.php, accessed in July 2019, Botswana Annual Five-Year Age Group Population Estimates by Sex for 2000 to 2025: National and First-, Second-, and Third-Order Administrative Divisions (2018)."},{"key":"70203_CR13","unstructured":"Statistics Botswana, Table 6: HIV Prevalence Rate by District. Botswana Aids Impact Survey IV 2013. Statistical report. 2013."},{"key":"70203_CR14","doi-asserted-by":"publisher","first-page":"e80589","DOI":"10.1371\/journal.pone.0080589","volume":"8","author":"V Novitsky","year":"2013","unstructured":"Novitsky, V. et al. Phylogenetic relatedness of circulating HIV-1C variants in Mochudi, Botswana. PLoS ONE 8, e80589 (2013).","journal-title":"PLoS ONE"},{"key":"70203_CR15","doi-asserted-by":"crossref","unstructured":"Rasmussen, D. A. et al. Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa. Virus Evol. 4, vey037 (2018).","DOI":"10.1093\/ve\/vey037"},{"key":"70203_CR16","unstructured":"Otecko, N. et al. HIV transmission clusters in Zambia are smaller than in Europe: evidence from the HPTN-071 (PopART) study, BEEHIVE study, and individual-based models: Poster LBEPC21, in 12th International AIDS Society conference on HIV Science (International AIDS Society, Brisbane, Australia, 2023)."},{"key":"70203_CR17","doi-asserted-by":"publisher","first-page":"2262197","DOI":"10.1080\/16549716.2023.2262197","volume":"16","author":"KM Matlapeng","year":"2023","unstructured":"Matlapeng, K. M. et al. Accessing HIV services in Botswana: perspectives of men who have sex with men and other stakeholders. Glob. Health Action 16, 2262197 (2023).","journal-title":"Glob. Health Action"},{"key":"70203_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25455","volume":"23","author":"D Havlir","year":"2020","unstructured":"Havlir, D. et al. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? J. Int. AIDS Soc. 23, e25455 (2020).","journal-title":"J. Int. AIDS Soc."},{"key":"70203_CR19","doi-asserted-by":"crossref","unstructured":"Perriat, D. et al. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J. Int. AIDS Soc. 21, e25048 (2018).","DOI":"10.1002\/jia2.25048"},{"key":"70203_CR20","unstructured":"GISGeography, Geography of Botswana. Accessed 31 January 2022. https:\/\/gisgeography.com\/botswana-map\/ (2022)."},{"key":"70203_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen, M. S. et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med. 375, 830\u2013839 (2016).","journal-title":"N. Engl. J. Med."},{"key":"70203_CR22","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/infdis\/jir651","volume":"204","author":"SH Eshleman","year":"2011","unstructured":"Eshleman, S. H. et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J. Infect. Dis. 204, 1918\u201326 (2011).","journal-title":"J. Infect. Dis."},{"key":"70203_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09139-4","volume":"10","author":"O Ratmann","year":"2019","unstructured":"Ratmann, O. et al. Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis. Nat. Commun. 10, 1411 (2019).","journal-title":"Nat. Commun."},{"key":"70203_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/molbev\/msx304","volume":"35","author":"C Wymant","year":"2017","unstructured":"Wymant, C. et al. PHYLOSCANNER: inferring transmission from within- and between-host pathogen genetic diversity. Mol. Biol. Evol. 35, 719\u2013733 (2017).","journal-title":"Mol. Biol. Evol."},{"key":"70203_CR25","unstructured":"R Core Team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria (2021)."},{"key":"70203_CR26","doi-asserted-by":"publisher","unstructured":"Magosi, L. E., DeGruttola, V. & Lipsitch, M. Unpacking Sources of Transmission in HIV Prevention Trials with Deep-sequence Pathogen Data. URL: https:\/\/github.com\/magosil86\/spillover-infections. https:\/\/doi.org\/10.5281\/zenodo.17641167 (2025).","DOI":"10.5281\/zenodo.17641167"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70203-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:27:59Z","timestamp":1777505279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70203"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70203-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consulting fees. M.L.: Merck, University of Virginia Miller Center, Janssen. Unpaid consulting. M.L.: Janssen, Pfizer, Astra Zeneca; Payment or honoraria for lectures, presentations, speaker\u2019s bureaus, manuscript writing or educational events. M.L.: Sanofi Pasteur, Bristol Myers Squibb; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid. S.L.: Member, Finance Board; member, Board of Directors; both for the Botswana Harvard AIDS Institute Partnership (unpaid). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3935"}}